Cargando…
TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner
Our neoadjuvant clinical trial of a GM-CSF secreting allogeneic pancreas tumor vaccine (GVAX) revealed the development of tertiary lymphoid aggregates (TLAs) within the pancreatic ductal adenocarcinoma (PDA) tumor microenvironment 2 weeks after GVAX treatment. Microarray studies revealed that multip...
Autores principales: | Soares, Kevin C., Rucki, Agnieszka A., Kim, Victoria, Foley, Kelly, Solt, Sara, Wolfgang, Christopher L., Jaffee, Elizabeth M., Zheng, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767487/ https://www.ncbi.nlm.nih.gov/pubmed/26515728 |
Ejemplares similares
-
Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer
por: Murphy, Adrian G., et al.
Publicado: (2017) -
Self-Regulatory Capacities Are Depleted in a Domain-Specific Manner
por: Zhang, Rui, et al.
Publicado: (2017) -
Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer
por: Huang, Huocong, et al.
Publicado: (2019) -
Pancreatic cancer triggers diabetes through TGF-β–mediated selective depletion of islet β-cells
por: Parajuli, Parash, et al.
Publicado: (2020) -
TGFβ: Signaling Blockade for Cancer Immunotherapy
por: Chen, Szu-Ying, et al.
Publicado: (2022)